These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Tervaert JW; Heeringa P Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415 [TBL] [Abstract][Full Text] [Related]
4. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Borgmann S; Haubitz M Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S79-86. PubMed ID: 15675141 [TBL] [Abstract][Full Text] [Related]
5. The antineutrophil cytoplasmic antibody-associated vasculitides. Seo P; Stone JH Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387 [TBL] [Abstract][Full Text] [Related]
6. ANCA vasculitis meets epigenetics--closing in on the molecular roots of disease. Zeisberg M Nephrol Dial Transplant; 2011 Apr; 26(4):1146-8. PubMed ID: 21273237 [No Abstract] [Full Text] [Related]
7. Newer insights into the aetiology and pathogenesis of myeloperoxidase associated autoimmunity. Schmitt WH Jpn J Infect Dis; 2004 Oct; 57(5):S7-8. PubMed ID: 15507771 [TBL] [Abstract][Full Text] [Related]
8. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides. Tervaert JW; Stegeman CA; Kallenberg CG Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):241-5. PubMed ID: 8946592 [No Abstract] [Full Text] [Related]
9. Antineutrophil cytoplasmic antibody-associated vasculitis: autoinflammation, autodestruction and autoimmunity--key to new therapies. Lamprecht P; Gross WL Trends Immunol; 2008 Dec; 29(12):587-8. PubMed ID: 18951843 [No Abstract] [Full Text] [Related]
10. The pathogenesis of ANCA-associated vasculitides: old hypotheses and new insights. Hänsch GM; Iking-Konert C; Andrassy K Clin Nephrol; 2005 Dec; 64(6):460-4. PubMed ID: 16370160 [TBL] [Abstract][Full Text] [Related]
11. Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals. Seta N; Tajima M; Kobayashi S; Kawakami Y; Hashimoto H; Kuwana M Mod Rheumatol; 2008; 18(6):593-600. PubMed ID: 18806928 [TBL] [Abstract][Full Text] [Related]
12. Immunopathology and new therapeutic considerations in ANCA-associated vasculitides. Gross WL Autoimmun Rev; 2004 Jun; 3 Suppl 1():S47-8. PubMed ID: 15309793 [No Abstract] [Full Text] [Related]
13. [Neutrophil polynuclear anticytoplasmic antibodies in systemic vasculitides]. Guillevin L Rev Mal Respir; 2000 Jun; 17(3):623-8. PubMed ID: 10951957 [No Abstract] [Full Text] [Related]